Keysight Technologies Announces $10M Investment In EMVision, An Australian Medical Device Company Focused On Developing Innovative Portable Brain Imaging Technology
Portfolio Pulse from Benzinga Newsdesk
Keysight Technologies has invested $10M in EMVision, an Australian medical device company, to support the development of portable brain imaging technology. This investment marks Keysight's first global investment in medical imaging innovation and provides EMVision with a fully funded path to market for its emu™ device. The technology aims to improve stroke care by enabling rapid diagnostics in settings where traditional imaging is unavailable. EMVision also plans to develop a first responder device for use in ambulances. Keysight will acquire an 8.73% shareholding in EMVision.
February 28, 2024 | 10:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Keysight Technologies' $10M investment in EMVision represents its first foray into medical imaging, potentially diversifying its portfolio and entering a new market.
Keysight's investment in EMVision could signal a strategic diversification into healthcare technology, a sector with growing demand for innovative solutions. This move might attract investor interest due to the potential for new revenue streams and market expansion. However, the actual impact on stock price will depend on the success of the emu™ device's market entry and adoption.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90